Trial Profile
Randomised clinical trial to assess efficacy of two insulin protocols in hospitalised subjects with type 2 diabetes mellitus receiving medium/high dose of corticosteroids
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2013
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary) ; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 30 Jul 2013 New trial record